Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) to Issue $0.30 Quarterly Dividend

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) declared a quarterly dividend on Monday, August 3rd. Stockholders of record on Friday, August 14th will be given a dividend of 0.30 per share by the real estate investment trust on Monday, August 31st. This represents a c) annualized dividend and a dividend yield of 5.8%. The ex-dividend date is Friday, August 14th.

Sabra Healthcare REIT has decreased its dividend payment by an average of 0.0%annually over the last three years. Sabra Healthcare REIT has a dividend payout ratio of 153.8% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities analysts expect Sabra Healthcare REIT to earn $1.59 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 75.5%.

Sabra Healthcare REIT Stock Down 2.6%

Shares of SBRA opened at $20.61 on Tuesday. The stock has a market capitalization of $5.20 billion, a price-to-earnings ratio of 32.71, a price-to-earnings-growth ratio of 1.64 and a beta of 0.64. The business’s 50 day simple moving average is $19.77 and its 200-day simple moving average is $19.93. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. Sabra Healthcare REIT has a 1 year low of $17.17 and a 1 year high of $22.77.

Wall Street Analysts Forecast Growth

SBRA has been the subject of a number of recent research reports. Truist Financial raised their price target on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Cantor Fitzgerald upped their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Raymond James Financial began coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, June 17th. They set an “underperform” rating for the company. Scotiabank dropped their price target on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a research report on Thursday, June 18th. Finally, Weiss Ratings lowered shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research note on Thursday, June 4th. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $22.25.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.